The non-coding transcriptome as a dynamic regulator of cancer metastasis Francesco CreaPier Luc ClermontCheryl D. Helgason NON-THEMATIC REVIEW Open access 18 December 2013 Pages: 1 - 16
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition Benoît ThibaultMagali CastellsBettina Couderc NON-THEMATIC REVIEW 20 December 2013 Pages: 17 - 39
Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade B. N. SinghHarikesh Bahadur SinghBraj Raj Singh NON-THEMATIC REVIEW 04 January 2014 Pages: 41 - 85
GAP-independent functions of DLC1 in metastasis David BarrasChristian Widmann NON-THEMATIC REVIEW 15 December 2013 Pages: 87 - 100
Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer Suh Youn KoGregory L. BlatchCrispin R. Dass NON-THEMATIC REVIEW 15 December 2013 Pages: 101 - 113
Ribosomal proteins as novel players in tumorigenesis A. de las Heras-RubioL. PeruchoM. E. LLeonart NON-THEMATIC REVIEW 28 December 2013 Pages: 115 - 141
The promise of sonodynamic therapy Matthew Trendowski NON-THEMATIC REVIEW 18 December 2013 Pages: 143 - 160
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine Sarah DerksArjen H. G. ClevenManon van Engeland NON-THEMATIC REVIEW Open access 28 December 2013 Pages: 161 - 171
The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy Hai WangYu-Chen DuShou-Ching Tang NON-THEMATIC REVIEW 18 December 2013 Pages: 173 - 181
Oxygen regulates molecular mechanisms of cancer progression and metastasis Kartik GuptaEsha MadanRajan Gogna NON-THEMATIC REVIEW 15 December 2013 Pages: 183 - 215
Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation Rainer J. KlementColin E. Champ NON-THEMATIC REVIEW Open access 17 January 2014 Pages: 217 - 229
Platelets and cancer: a casual or causal relationship: revisited David G. MenterStephanie C. TuckerKenneth V. Honn NON-THEMATIC REVIEW 03 April 2014 Pages: 231 - 269
Concomitant resistance and early-breast cancer: should we change treatment strategies? Carlos M. GalmariniOlivier TredanFelipe C. Galmarini Clinical 18 December 2013 Pages: 271 - 283
Why anti-Bcl-2 clinical trials fail: a solution Y. HarazonoK. NakajimaA. Raz Clinical 15 December 2013 Pages: 285 - 294
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors Alberto OcañaOrit FreedmanAtanasio Pandiella Clinical 15 December 2013 Pages: 295 - 307
Adoptive immunotherapy of metastatic breast cancer: present and future Stefan StefanovicFlorian SchuetzChristoph Domschke Clinical 13 December 2013 Pages: 309 - 320
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside Matteo SantoniDaniele SantiniStefano Cascinu Clinical 13 December 2013 Pages: 321 - 331
Bone metastases in hepatocellular carcinoma: an emerging issue Vito LongoOronzo BrunettiFranco Silvestris Clinical 20 December 2013 Pages: 333 - 342
Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges Rocio Garcia-Carbonero EditorialNotes 20 December 2013 Pages: 343 - 344
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets J. CapdevilaA. MeekerA. Scarpa OriginalPaper 28 December 2013 Pages: 345 - 351
Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges J. P. CastañoA. SundinK. Öberg OriginalPaper 05 January 2014 Pages: 353 - 359
Pancreatic NETs: where do we stand now? S. FaivreD. CastellanoR. Salazar OriginalPaper 23 January 2014 Pages: 361 - 366
Systemic therapeutic strategies for GEP-NETS: what can we expect in the future? E. RaymondR. García-CarboneroM. Pavel OriginalPaper 28 December 2013 Pages: 367 - 372
